These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 649996)

  • 21. Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections.
    Nelson JD; Bucholz RW; Kusmiesz H; Shelton S
    J Pediatr Orthop; 1982 Aug; 2(3):255-62. PubMed ID: 7130382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of serious anaerobic infections.
    Greenberg RN; Scalcini MC; Sanders CV; Lewis AC
    Scand J Infect Dis Suppl; 1980; suppl 25():84-8. PubMed ID: 7010541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gentamicin therapy administered by intermittent intravenous injections.
    Korner B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:15-2. PubMed ID: 4521603
    [No Abstract]   [Full Text] [Related]  

  • 24. Cefamandole for treatment of obstetrical and gynecological infections.
    Cunningham FG; Gilstrap LC; Kappus SS
    Scand J Infect Dis Suppl; 1980; suppl 25():75-82. PubMed ID: 7010540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy of acute bone and joint infections.
    Bajpai J; Chaturvedi SN; Khanuja SP
    Int Surg; 1977 Mar; 62(3):172-4. PubMed ID: 323174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cephalexin: clinical and laboratory studies.
    Lyons RW; Andriole VT
    Yale J Biol Med; 1971 Oct; 44(2):187-98. PubMed ID: 5123053
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of clinical trials with cephadrine in children].
    Steinitz H
    Infection; 1973; 1(3):163-9. PubMed ID: 4597099
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Wilson KJ
    J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327
    [No Abstract]   [Full Text] [Related]  

  • 29. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E; Brogden RN
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of mediastinal infection following cardiac surgery. An experience utilizing continuous irrigation with povidone-iodine.
    Thurer RJ; Bognolo D; Vargas A; Isch JH; Kaiser GA
    J Thorac Cardiovasc Surg; 1974 Dec; 68(6):962-8. PubMed ID: 4608531
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and laboratory investigation of cefamandole in infections of infants and children.
    Azimi PA
    Antimicrob Agents Chemother; 1978 Jun; 13(6):955-7. PubMed ID: 307939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefamandole nafate: an evaluation of antibacterial activity, serum levels, clinical effect, and incidence of side reactions in 58 patients.
    Ekwall E; Holmgren EB; Lundbergh P; Svanbom M; Tunevall G
    Scand J Infect Dis; 1979; 11(2):135-9. PubMed ID: 462128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbenicillin plus cefamandole in the treatment of infections in patients with cancer.
    Bodey GP; Ketchel S; Rodriguez V
    J Infect Dis; 1978 May; 137 Suppl():S139-S143. PubMed ID: 649998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M; Deamer RL; Prichard JG
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefamandole--effectiveness against anaerobes: supplementary remarks.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():94-5. PubMed ID: 7010543
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis.
    Cooper RH; Savitch CB; Joseph WP; Mills J
    Antimicrob Agents Chemother; 1981 Feb; 19(2):256-9. PubMed ID: 7347561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime.
    Peterson CD; Lake KD; Arom KV; Love KR
    Drug Intell Clin Pharm; 1987 Sep; 21(9):728-32. PubMed ID: 3498617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefamandole in the treatment of soft tissue infections.
    Ramírez-Ronda CH; Quiñones-Soto R; Lugo-Velázquez A; Bermúdez RH
    Chemotherapy; 1982; 28(3):224-8. PubMed ID: 7094663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of latamoxef as initial therapy of bone and joint infections in childhood.
    Aronoff SC; Scoles PV; Reed MD; Kelley F; Husak M; Blumer JL
    Chemotherapy; 1984; 30(5):337-44. PubMed ID: 6333322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.